Key Takeaways for Northern Virginia Owners
- In 2026, private buyers usually value practices as a percentage of collections (65–85%), while DSOs use EBITDA multiples. That difference can create a 40–80% valuation gap.
- Northern Virginia practices with $1M–$3M+ in revenue can see premium DSO multiples (5.0x–11.0x) when hygiene is strong, payer mix skews FFS, and the office sits in desirable metro locations.
- Owners can reduce the risk of price cuts during due diligence by getting a diligence-grade, CPA-led EBITDA valuation before speaking with buyers.
- A structured competitive bid process that attracts multiple offers can often deliver valuations around 30% higher and an 85–90% close rate compared with single-buyer negotiations.
- Schedule a free, confidential discovery call with McLerran & Associates to review a detailed valuation and plan your Northern Virginia practice exit.
2026 Northern Virginia DSO EBITDA Multiples by Practice Size
Northern Virginia practices often sit toward the upper end of national DSO multiple ranges. The region’s dense suburbs, high household incomes, and strong commercial insurance mix can be some of the main factors behind that premium. Metro practices in MSAs with populations above 100,000 can command premiums over rural peers because of population density and DSO buyer concentration.
| Practice Revenue | Typical EBITDA Margin Range | Key Northern Virginia Value Drivers | Directional DSO Multiple Range |
|---|---|---|---|
| $1M–$1.5M | 15–25% | Hygiene % of collections, FFS/PPO mix, associate coverage, Fairfax/Arlington location density | 5.0x–6.5x adjusted EBITDA |
| $1.5M–$3M | 20–30% | Multi-provider depth, hygiene above 28–33% of collections, low owner dependence, Loudoun growth corridor | 7.0x–9.0x adjusted EBITDA |
| $3M+ | 25–35% | Platform-ready operations, specialty mix, associate-led production, regional DSO cluster fit | 9.0x–11.0x+ adjusted EBITDA |
Several local factors can push a Northern Virginia practice toward the higher end of these bands.
- Hygiene production above 28–33% of collections. A hygiene base above this threshold supports premium multiples within a given size band because DSOs often view recurring hygiene revenue as annuity-like cash flow.
- Fee-for-service (FFS) mix. A practice with a high FFS payer mix can generate more revenue per procedure than the same volume under contracted PPO rates, which directly increases EBITDA and the multiple applied to it.
- Location premium. Competitive bidding in desirable metros can push multiples above rural benchmarks. Fairfax, Arlington, and Loudoun submarkets often qualify as high-demand corridors.
- Medicaid exposure. Medicaid revenue above a significant share of total collections can trigger an EBITDA discount from DSO buyers.
How DSOs View Your Numbers Before Making an Offer
Owners benefit from walking into buyer conversations with a valuation that will stand up to scrutiny. DSOs typically normalize EBITDA by replacing the owner’s total compensation with a market-rate associate salary, often 25–35% of personal production. They then add back discretionary, personal, and non-recurring expenses to estimate true transferable earnings.
DSO buyers also reconcile production to collections, normalize owner and provider compensation, test hygiene and patient-retention durability, and evaluate doctor concentration before issuing a letter of intent (LOI). A “free” valuation that skips this work often gets re-traded during due diligence when the buyer’s quality-of-earnings team finds gaps and pushes the price down.
McLerran & Associates has evaluated more than 10,000 dental practices. The firm builds each valuation as CPA-led, diligence-grade work before the deal goes to market so the number is more likely to hold when buyers review the details.
Create Competition for Your Northern Virginia Practice
Once you have a defensible valuation in hand, the next step is avoiding one-off negotiations. A practice owner who speaks with one DSO has one offer and limited negotiating power. McLerran’s structured bid process, typically 45–60 days, can generate around 10 offers from a vetted pool of well-qualified DSO and private equity buyers.
Northern Virginia’s dense suburban population, strong hygiene metrics, and commercial payer mix can attract several buyer types at once. These can include large national platforms, regional add-on buyers, and emerging IDSOs (Independent Dental Support Organizations, which acquire a majority stake while preserving the practice’s individual brand).
Practices taken to market through a structured multiple-buyer solicitation process receive final sale values averaging 50% above initial unsolicited offers. McLerran has blacklisted DSOs known for poor post-close environments, so those buyers do not reach the table.
Schedule a free, confidential discovery call with McLerran & Associates to see how a competitive process can change the economics of your Northern Virginia practice sale.
Comparing DSO Deal Components Over Time
DSO offers usually spread value across several pieces rather than a single check. A typical structure includes three main components.
- Cash at close. This portion is guaranteed at signing and commonly represents a substantial share of total consideration.
- Rollover equity. This is an ownership stake in the DSO platform. It can sit at the joint-venture (JV) level, which may pay regular distributions, or at the holding-company (HoldCo) level, which can offer higher upside at a future platform sale. Rollover equity is typically illiquid for several years and can represent a meaningful share of total proceeds.
- Earnout. These are contingent payments tied to post-close performance metrics such as EBITDA, collections, or patient retention, commonly measured over one to three years.
A simple example can highlight how timing affects outcomes. A $2M-revenue Northern Virginia practice with a 25% EBITDA margin ($500K normalized EBITDA) at a 7x multiple produces a $3.5M headline value. A substantial cash-at-close percentage creates a large guaranteed amount at signing, with the balance in equity and earnout.
Headline numbers alone do not show what an owner may actually receive over time. McLerran models each finalist’s offer across 3, 5, and 7-year horizons, including conservative recapitalization assumptions and after-tax treatment. Much of a DSO deal’s goodwill component can qualify for long-term capital gains rates rather than ordinary income, which can materially affect net proceeds.
Before any offer reaches the owner, McLerran also reviews each buyer’s financial strength, management track record, and post-close reputation so only credible buyers move forward.
Choosing Between DSO Affiliation and Private Sale
Northern Virginia owners in the $1.5M–$3M revenue “middle” often face a real choice between DSO and private-buyer paths. The table below outlines several key differences.
| Dimension | DSO Affiliation | Private Buyer (Doctor-to-Doctor) |
|---|---|---|
| Valuation method | EBITDA multiple (in a typical range for $1M–$3M EBITDA add-on tier) | Percentage of annual collections |
| Post-close work requirement | Typically a multi-year employment agreement | Short transition, then full exit |
| Equity upside potential | Yes, potential “second bite” at DSO recapitalization | No, clean exit with full liquidity at close |
| Clinical autonomy post-close | Reduced, DSO controls scheduling, vendors, staffing | High, buyer often preserves existing culture |
Because McLerran works both paths in roughly equal measure, the firm can quantify what your practice may be worth in each market. That comparison helps owners choose based on data rather than assumptions. Many clients see higher valuations than they might achieve on their own or with a generalist broker, and McLerran’s sell-side-only mandate keeps its incentives aligned with the seller.
Questions DSOs Commonly Ask in Due Diligence
DSO buyers usually follow a consistent due diligence playbook. Their questions aim to test production durability, team stability, and risk areas before finalizing terms.
- What percentage of total production comes from the owner-doctor versus associates and hygienists?
- What is the practice’s hygiene recall rate, and what share of collections does hygiene represent?
- What is the payer mix (FFS, PPO, Medicaid), and which specific carriers are in-network?
- How many active patients does the practice carry, and what is the 12-month retention rate?
- What are the lease terms, and how many years remain on the current agreement?
- Are there any open OSHA citations, payer audits, or unresolved compliance matters?
- What is associate and hygienist tenure, and are retention agreements in place?
- Does the practice use digital workflows such as CBCT, intraoral scanners, or cloud practice management software?
Red Flags to Watch for in DSO Offers
Some DSO offers contain terms that can significantly reduce real-world proceeds. Owners can watch for several common warning signs.
- Cliff earnout structures. Missing a target by a small margin causes the entire earnout to disappear instead of paying a partial amount.
- Undefined overhead allocations. The DSO can charge management fees or depreciation to the practice P&L after close, which reduces EBITDA and can limit earnout payments.
- No acceleration clause. If the DSO sells during your earnout period, an acceleration clause can protect your contingent payments. Without it, you may lose value.
- Holding-company equity with no clear liquidity path. Equity that lacks a defined exit timeline functions more like speculation than compensation.
- Single-buyer process. An offer from one DSO without competition usually reflects the buyer’s best outcome, not the seller’s.
- Undercapitalized buyer. A practice can be more valuable to a DSO with existing regional density and recruiting infrastructure. A buyer without local support may struggle post-close, which can put retained equity at risk.
- Vague employment terms. Compensation tied to a percentage of collections with aggressive production minimums can reduce effective deal value over a multi-year work-back.
Frequently Asked Questions
How is EBITDA calculated for a Northern Virginia dental practice, and why can it matter more than collections?
EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, estimates a practice’s operating profit after several adjustments. Advisors replace the owner’s total compensation with a market-rate associate salary and add back personal, discretionary, and non-recurring expenses. DSO buyers apply a multiple to this normalized figure instead of gross collections because EBITDA reflects what the practice may earn under new ownership.
A Northern Virginia practice generating $2M in collections with a 25% EBITDA margin ($500K normalized) can be worth far more to a DSO than a $2M-collections practice with a 15% margin ($300K normalized). Collections-based valuations, which are common in private-buyer deals, do not capture this difference. That gap is one reason the same practice can carry a 40–80% higher headline value in the DSO market.
Should a Northern Virginia practice owner in the $1.5M–$3M revenue range sell to a DSO or a private buyer?
Both paths can work for practices in this band, and the better fit depends on goals, timing, and practice profile. DSO affiliation often produces a higher headline valuation because institutional buyers apply EBITDA multiples supported by cheaper capital and multiple arbitrage. That path usually includes a 3–5 year post-close employment commitment, reduced clinical autonomy, and a portion of proceeds in illiquid equity.
A private-buyer sale typically delivers a lower headline but 80–100% cash at close, a clean exit in 30–90 days, and no equity rollover risk. Because McLerran & Associates works both paths, the firm can quantify value in each market so the owner makes an informed choice. Owners in this “Venn diagram middle” often benefit from that comparison before committing to either direction.
What local factors in Fairfax, Arlington, and Loudoun County can increase a dental practice’s DSO valuation?
Northern Virginia’s suburban demographics create several advantages for qualifying practices. High household incomes in Fairfax, Arlington, and Loudoun can support stronger fee-for-service and elective procedure mix, which DSO buyers often underwrite at premium multiples relative to Medicaid-heavy practices. Dense population corridors increase the chance that a practice sits inside an existing DSO’s regional cluster, which can drive higher bids because the buyer can share administrative services, staffing, and marketing.
Strong hygiene programs, which are common in commercially insured patient bases, signal recurring revenue that DSOs tend to model favorably. Practices with multiple providers, modern digital workflows, and leases with 5 or more years remaining often sit toward the upper end of applicable multiple ranges in this market.
What is the McLerran & Associates process for Northern Virginia practice owners, and how long does it take?
McLerran’s engagement usually begins with a comprehensive, CPA-led EBITDA analysis and practice valuation. The team builds this from practice management data and financial statements and explains each add-back in plain language. For owners weighing both exit paths, the firm quantifies value in the private-buyer and DSO markets so both options are clear.
Next, McLerran prepares a marketing deck and virtual data room, then runs a structured competitive bid process, typically 45–60 days, soliciting offers from a vetted pool of DSO and private equity buyers. Poorly run DSOs are excluded. The process narrows from initial offers to in-person meetings with top finalists.
McLerran negotiates the letter of intent, models each finalist’s deal across 3, 5, and 7-year horizons, and supports quality-of-earnings review through diligence so the agreed value is more likely to hold. The full engagement from first conversation to close usually runs several months, with McLerran acting as advocate and buffer at each stage. If an owner is not ready to sell, McLerran can update the valuation at no charge a year later.
Next Step: Schedule Your Free, Confidential Discovery Call
A quick estimate or a single-buyer conversation can quietly set the ceiling on what a Northern Virginia practice owner takes home. McLerran & Associates’ CPA-led EBITDA analysis, structured competition, and sell-side-only focus are designed to improve that outcome, building on the valuation lift and transaction rate described earlier for owners of premier practices.
Andrew Kobylski leads McLerran’s Northern Virginia office and works exclusively with practice owners facing this decision. Whether a sale is close or still several years away, owners often benefit from understanding their options before a buyer presents terms.
Schedule a free, confidential discovery call with McLerran & Associates by calling (512) 900-7989, emailing info@dentaltransitions.com, or scheduling online.
Owners who are not ready to sell yet can still get educated. The McLerran M&A Summit — October 29–30, 2026 is a dental-only event built for undecided owners. Attendees receive 4 CE credits and a complimentary practice valuation (a $2,500 value). The summit offers a low-pressure way to learn from McLerran’s full team before making one of the most significant financial decisions of a career.
